The urology department of the Mohammed V Military Instruction Hospital and the Moroccan Group of Andrology and Sexual Medicine (GRAMS) are organizing, in Rabat this Friday, September 23, 2022, a scientific meeting on diagnostic and therapeutic news in the prostate cancers. Today, via the perineal route at the level of the small pelvis, non-invasive biopsies can be performed, guided by ultrasound and MRI for a more precise diagnosis of a malignant tumor pathology of the prostate. Classically, to diagnose an abnormality of the prostate (cancer or benign tumor), the urologist-surgeon goes rectally to take a sample (biopsy). Psychologically, this is still traumatic in our Moroccan context. Men will lose a lot of time because of this obstacle. Fortunately, science is evolving. Today, via the perineal route at the level of the small pelvis, non-invasive biopsies can be performed, guided by ultrasound and MRI. Morocco is on time for this cutting-edge medical event. This continuing medical education meeting on one of the most established urological pathologies will benefit from the expertise of a specialized team from the Nantes-Atlantis urological establishment, led by Dr Thierry Rousseau.
The Nantes medical team presented a long experience in the diagnosis of prostate cancer using a non-invasive technique called “Biopsy of the prostate by the transperineal route and image fusion”. Moroccan urologists from the public, private and military sectors will participate in workshops on this new prostate biopsy technique, led by the Nantes urology team of Dr. Thierry Rousseau. This innovative technology in image-assisted urology focused on prostate cancer has the main challenge of bringing quality and precision to minimally invasive interventions during the stages of diagnosis and treatment of the most common cancer in men. It is an assistance to the surgical gesture, both by guiding the doctor towards the suspicious zone during the biopsy, and by recording the cartography of the biopsies for better quality control. One of the originalities of his approach is to merge MRI and ultrasound data in real time on a single image. Two imaging techniques requiring conditions that are usually incompatible and therefore cannot be implemented at the same time in the patient. For the first time, 3D ultrasound, image fusion, organ tracking are combined in a unique and intuitive device allowing the urologist to control the accuracy and quality of the prostate biopsy and allowing the choice treatment tailored to each patient. It is essential to specify that prostate cancer is the first cancer in men and corresponds to the second cause of death by cancer in men.
This is now a major public health issue, particularly given the increase in life expectancy. If its screening is based on the PSA blood test and clinical examination (digital examination), its diagnosis requires the histological analysis of prostate samples. Currently, in clinical routine, these prostate biopsies are performed endorectally, using ultrasound guidance. Most often, the cancer is not visible in the ultrasound image and this is used to take a dozen samples (or carrots), distributed as best as possible in the prostate. To increase the precision and the contribution of these biopsies, the use of data acquired by magnetic resonance imaging (MRI), as well as the fusion of ultrasound and MRI images is today a therapy in the process of being validated and carried out in many establishments with dedicated tools. The objective of the meeting between urologists from Rabat, Kenitra and Nantes is to present the practical methods of carrying out these prostate biopsies in Morocco using image fusion and to discuss the advantages and benefits. The scientific meeting on new technologies for diagnosis and treatment in urology between urologists from Nantes and Rabat will also focus on robotic laparoscopic techniques, surgery for urinary incontinence and prolapse in women, perineal vaginal surgery by strip or by sacral neuro-modulation “bladder place maker”.
Doctor Anouar Cherkaoui